nach oben

Cancer Causes & Control

Erschienen in:

14.09.2019 | Original Paper

Race/ethnicity and lung cancer survival in the United States: a meta-analysis

verfasst von: Madelyn Klugman, Xiaonan Xue, H. Dean Hosgood III

Erschienen in: Cancer Causes & Control | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Lung cancer mortality has been shown to vary by race and ethnicity in cancer registries; however, studies often do not account for smoking status. We sought to summarize the independent contribution of race and ethnicity to survival in US lung cancer patients, accounting for important variables including smoking status.

Methods

PubMed was used to identify 1,877 potentially eligible studies of which 27 were included. Studies were excluded if they did not account for age, race and/or ethnicity, and smoking status. Fixed- and random-effects meta-analyses were conducted using the reported adjusted hazard ratios (HR) of Hispanic ethnicity and Asian and African-American race compared to Non-Hispanic whites (NHWs) on overall survival in lung cancer.

Results

Hispanic ethnicity and Asian race were associated with decreased adjusted risk of death (Hispanic: N_studies = 5, N_subjects = 108,810, HR = 0.95, 95% CI 0.90–1.00; Asian: N_studies = 6, N_subjects = 128,950, HR = 0.86, 95% CI 0.81–0.90). The results were similar when excluding studies of solely never-smokers. There was no significant difference in survival between African-American and white race after adjustment (N_studies = 10, N_subjects = 131,378, HR = 0.98, 95% CI 0.96–1.01). Other prognostic factors were female gender (HR = 0.88, 95% CI 0.87–0.89), unmarried status (HR = 1.08, 95% CI 1.04–1.11), ever-smoking status (HR = 1.11, 95% CI 1.08–1.15), having comorbidities (HR = 1.39, 95% CI 1.24–1.56), and treatment receipt (surgery: HR = 0.33, 95% CI 0.32–0.34; radiation: HR = 0.87, 95% CI 0.85–0.88; chemotherapy: HR = 0.64, 95% CI 0.63–0.65).

Conclusions

Even after adjustment for clinical factors and smoking status, Hispanics and Asians experienced improved survival compared to NHWs. Future studies are needed to elucidate the drivers of these survival disparities.

Nur mit Berechtigung zugänglich

Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30CrossRefPubMed

American Cancer Society (2019) Cancer facts & figures for African Americans 2019–2021. American Cancer Society, Atlanta

Aizer AA, Wilhite TJ, Chen MH et al (2014) Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120:1532–1539CrossRefPubMed

Shugarman LR, Mack K, Sorbero ME et al (2009) Race and sex differences in the receipt of timely and appropriate lung cancer treatment. Med Care 47:774–781CrossRefPubMed

Saeed AM, Toonkel R, Glassberg MK et al (2012) The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the survival, epidemiology, and end results database. Cancer 118:4495–4501CrossRefPubMed

Siegel DA, Henley SJ, Wike JM et al (2018) Capture of tobacco use among population-based registries: findings from 10 National Program of Cancer Registries states. Cancer 124:2381–2389CrossRefPubMed

Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P (2004) Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 125:27–37CrossRefPubMed

Leduc C, Antoni D, Charloux A, Falcoz PE, Quoix E (2017) Comorbidities in the management of patients with lung cancer. Eur Respir J 49:1601721CrossRefPubMed

US Census Bureau, US Department of Commerce (2017) Race & ethnicity

10.

Xu T, Wei Q, Lopez Guerra JL et al (2012) HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84:e229–e235CrossRefPubMedPubMedCentral

11.

Ou SH, Ziogas A, Zell JA (2009) Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol 4:1083–1093CrossRefPubMed

12.

Williams CD, Salama JK, Moghanaki D, Karas TZ, Kelley MJ (2016) Impact of race on treatment and survival among U.S. veterans with early-stage lung cancer. J Thorac Oncol 11:1672–1681CrossRefPubMed

13.

Clement-Duchene C, Stock S, Xu X et al (2016) Survival among never-smokers with lung cancer in the cancer care outcomes research and surveillance study. Ann Am Thorac Soc 13:58–66CrossRefPubMedPubMedCentral

14.

Yang R, Cheung MC, Byrne MM et al (2010) Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer 116:2437–2447PubMed

15.

Tannenbaum SL, Koru-Sengul T, Zhao W, Miao F, Byrne MM (2014) Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status. Cancer J 20:237–245CrossRefPubMed

16.

Nikolakopoulou A (2014) Demystifying fixed and random effects meta-analysis. Evid Based Mental Health 17:53–57CrossRef

17.

Barili F, Parolari A, Kappetein PA, Freemantle N (2018) Statistical primer: heterogeneity, random- or fixed-effects model analyses? Interact Cardiovasc Thorac Surg 27:317–321CrossRefPubMed

18.

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560CrossRefPubMedPubMedCentral

19.

Ademuyiwa FO, Johnson CS, White AS et al (2007) Prognostic factors in stage III non-small-cell lung cancer. Clin Lung Cancer 8:478–482CrossRefPubMed

20.

Aldrich MC, Grogan EL, Munro HM, Signorello LB, Blot WJ (2013) Stage-adjusted lung cancer survival does not differ between low-income Blacks and Whites. J Thorac Oncol 8:1248–1254CrossRefPubMedPubMedCentral

21.

Biswas T, Walker P, Podder T, Efird JT (2015) Effect of race and insurance on the outcome of stage i non-small cell lung cancer. Anticancer Res 35:4243–4249PubMed

22.

Biswas T, Walker P, Podder T, Rosenman J, Efird J (2014) Important prognostic factors for lung cancer in tobacco predominant Eastern North Carolina: study based on a single cancer registry. Lung Cancer 84:116–120CrossRefPubMed

23.

Brasky TM, Baik CS, Slatore CG, Alvarado M, White E (2012) Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study. J Thorac Oncol 7:1503–1512CrossRefPubMedPubMedCentral

24.

Brzezniak C, Satram-Hoang S, Goertz HP et al (2015) Survival and racial differences of non-small cell lung cancer in the United States Military. J Gen Intern Med 30:1406–1412CrossRefPubMedPubMedCentral

25.

Elchoufani SE, Efird JT, O’Neal WT, Davies SW, Landrine H, Biswas T (2013) The relation of race and type of health insurance to long-term risk of mortality among lung cancer patients in rural Eastern North Carolina. N C Med J 74:464–469PubMed

26.

Enewold L, Mechanic LE, Bowman ED, Platz EA, Alberg AJ (2012) Association of matrix metalloproteinase-1 polymorphisms with risk of COPD and lung cancer and survival in lung cancer. Anticancer Res 32:3917–3922PubMedPubMedCentral

27.

Enewold L, Mechanic LE, Bowman ED et al (2009) Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomark Prev 18:215–222CrossRef

28.

Gomez SL, Chang ET, Shema SJ et al (2011) Survival following non-small cell lung cancer among Asian/Pacific Islander, Latina, and Non-Hispanic white women who have never smoked. Cancer Epidemiol Biomark Prev 20:545–554CrossRef

29.

Jones CC, Bush WS, Crawford DC et al (2017) Germline genetic variants and lung cancer survival in African Americans. Cancer Epidemiol Biomark Prev 26:1288–1295CrossRef

30.

Katcoff H, Wenzlaff AS, Schwartz AG (2014) Survival in women with NSCLC: the role of reproductive history and hormone use. J Thorac Oncol 9:355–361CrossRefPubMedPubMedCentral

31.

Mulligan CR, Meram AD, Proctor CD, Wu H, Zhu K, Marrogi AJ (2006) Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomark Prev 15:25–31CrossRef

32.

Ou SH, Ziogas A, Zell JA (2010) A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status. J Thorac Oncol 5:158–168CrossRefPubMed

33.

Ou SH, Ziogas A, Zell JA (2009) Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. J Thorac Oncol 4:37–43CrossRefPubMed

34.

Pennella E, Obasaju CK, Pohl G et al (2013) Prospective observational comparison of clinical outcomes between African-American and Caucasian patients receiving second-line treatment with pemetrexed for advanced non-small-cell lung cancer. Clin Lung Cancer 14:726–735CrossRefPubMed

35.

Pine SR, Mechanic LE, Ambs S et al (2007) Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst 99:1401–1409CrossRefPubMed

36.

Sausville LN, Jones CC, Aldrich MC, Blot WJ, Pozzi A, Williams SM (2017) Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival. PLoS ONE 12:e0180471CrossRefPubMedPubMedCentral

37.

Van Dyke AL, Cote ML, Prysak GM et al (2008) COX-2/EGFR expression and survival among women with adenocarcinoma of the lung. Carcinogenesis 29:1781–1787CrossRefPubMedPubMedCentral

38.

Vyfhuis MAL, Bhooshan N, Molitoris J et al (2017) Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer. Lung Cancer. 114:44–49CrossRefPubMed

39.

Wan YW, Beer DG, Guo NL (2012) Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma. Lung Cancer 76:98–105CrossRefPubMed

40.

Nakamura H, Ando K, Shinmyo T et al (2011) Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis. Ann Thorac Cardiovasc Surg 17:469–480CrossRefPubMed

41.

Arrieta O, Ramirez-Tirado LA, Baez-Saldana R, Pena-Curiel O, Soca-Chafre G, Macedo-Perez EO (2015) Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the “Hispanic paradox”. Lung Cancer 90:161–166CrossRefPubMed

42.

Ruiz JM, Steffen P, Smith TB (2013) Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. Am J Public Health 103:e52–e60CrossRefPubMedPubMedCentral

43.

Palloni A, Arias E (2004) Paradox lost: explaining the Hispanic adult mortality advantage. Demography 41:385–415CrossRefPubMed

44.

Arias E, Eschbach K, Schauman WS, Backlund EL, Sorlie PD (2010) The Hispanic mortality advantage and ethnic misclassification on US death certificates. Am J Public Health 100(Suppl 1):S171–S177CrossRefPubMedPubMedCentral

45.

Medina-Inojosa J, Jean N, Cortes-Bergoderi M, Lopez-Jimenez F (2014) The Hispanic paradox in cardiovascular disease and total mortality. Prog Cardiovasc Dis 57:286–292CrossRefPubMed

46.

Abraido-Lanza AF, Dohrenwend BP, Ng-Mak DS, Turner JB (1999) The Latino mortality paradox: a test of the “salmon bias” and healthy migrant hypotheses. Am J Public Health 89:1543–1548CrossRefPubMedPubMedCentral

47.

Turra CM, Elo IT (2008) The Impact of Salmon Bias on the Hispanic mortality advantage: new evidence from social security data. Popul Res Policy Rev 27:515–530CrossRefPubMedPubMedCentral

48.

Argeseanu Cunningham S, Ruben JD, Narayan KM (2008) Health of foreign-born people in the United States: a review. Health Place 14:623–635CrossRefPubMed

49.

Bolstad AL, Bungum T (2013) Diet, acculturation, and BMI in Hispanics living in southern Nevada. Am J Health Behav 37:218–226CrossRefPubMed

50.

Yoshida Y, Scribner R, Chen L, Broyles S, Phillippi S, Tseng T-S (2017) Role of age and acculturation in diet quality among Mexican Americans: findings from the National Health and Nutrition Examination Survey, 1999–2012. Prev Chronic Dis 14:E59CrossRefPubMedPubMedCentral

51.

Almeida J, Molnar BE, Kawachi I, Subramanian SV (2009) Ethnicity and nativity status as determinants of perceived social support: testing the concept of familism. Soc Sci Med 68:1852–1858CrossRefPubMed

52.

Kaplan RC, Bangdiwala SI, Barnhart JM et al (2014) Smoking among U.S. Hispanic/Latino adults: the Hispanic community health study/study of Latinos. Am J Prev Med 46:496–506CrossRefPubMedPubMedCentral

53.

Kondo KK, Rossi JS, Schwartz SJ, Zamboanga BL, Scalf CD (2016) Acculturation and cigarette smoking in Hispanic women: a meta-analysis. J Ethn Subst Abuse 15:46–72CrossRefPubMed

54.

Lui PP, Zamboanga BL (2018) A critical review and meta-analysis of the associations between acculturation and alcohol use outcomes among Hispanic Americans. Alcohol Clin Exp Res 42:1841–1862CrossRefPubMed

55.

Willey JZ, Rodriguez CJ, Moon YP et al (2012) Coronary death and myocardial infarction among Hispanics in the Northern Manhattan study: exploring the Hispanic paradox. Ann Epidemiol 22:303–309CrossRefPubMedPubMedCentral

56.

Soneji S, Tanner NT, Silvestri GA, Lathan CS, Black W (2017) Racial and ethnic disparities in early-stage lung cancer survival. Chest 152:587–597CrossRefPubMedPubMedCentral

57.

Schneiderman N, Chirinos DA, Avilés-Santa ML, Heiss G (2014) Challenges in preventing heart disease in hispanics: early lessons learned from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Prog Cardiovasc Dis 57:253–261CrossRefPubMedPubMedCentral

58.

Fenelon A, Chinn JJ, Anderson RN (2017) A comprehensive analysis of the mortality experience of hispanic subgroups in the United States: variation by age, country of origin, and nativity. SSM Popul Health 3:245–254CrossRefPubMedPubMedCentral

59.

Patel MI, Schupp CW, Gomez SL, Chang ET, Wakelee HA (2013) How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox. J Clin Oncol 31:3572–3578CrossRefPubMedPubMedCentral

60.

Reyes-Guzman CM, Pfeiffer RM, Lubin J et al (2017) Determinants of light and intermittent smoking in the United States: results from three pooled national health surveys. Cancer Epidemiol Biomark Prev 26:228–239CrossRef

61.

Watza D, Schwartz AG (2017) Addressing Underrepresented populations in lung cancer research: the Hispanic/Latino lung cancer registry identifies distinct mutation profiles for NSCLC. J Thorac Oncol 12:1744–1745CrossRefPubMedPubMedCentral

62.

LaPar DJ, Bhamidipati CM, Harris DA et al (2011) Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States. Ann Thorac Surg 92:434–439CrossRefPubMedPubMedCentral

63.

Vyfhuis MAL, Bentzen SM, Molitoris JK et al (2019) Patterns of care and survival in Stage III NSCLC among black and latino patients compared with white patients. Clin Lung Cancer 20(248–57):e4

64.

Thun MJ, Hannan LM, Adams-Campbell LL et al (2008) Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 5:e185CrossRefPubMedPubMedCentral

65.

Lan Q, He X, Shen M et al (2008) Variation in lung cancer risk by smoky coal subtype in Xuanwei, China. Int J Cancer 123:2164–2169CrossRefPubMedPubMedCentral

66.

Hosgood HD 3rd, Wei H, Sapkota A et al (2011) Household coal use and lung cancer: systematic review and meta-analysis of case–control studies, with an emphasis on geographic variation. Int J Epidemiol 40:719–728CrossRefPubMedPubMedCentral

67.

Ioannidis JP, Trikalinos TA (2007) The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 176:1091–1096CrossRefPubMedPubMedCentral

Titel: Race/ethnicity and lung cancer survival in the United States: a meta-analysis
verfasst von: Madelyn Klugman
Xiaonan Xue
H. Dean Hosgood III
Publikationsdatum: 14.09.2019
Verlag: Springer International Publishing
Erschienen in: Cancer Causes & Control / Ausgabe 11/2019
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-019-01229-4

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Race/ethnicity and lung cancer survival in the United States: a meta-analysis

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer

Relationship between West African ancestry with lung cancer risk and survival in African Americans

Differences in reported sun protection practices, skin cancer knowledge, and perceived risk for skin cancer between rural and urban high school students

Post-operative colorectal cancer surveillance: preference for optical colonoscopy over computerized tomographic colonography

Do breast quadrants explain racial disparities in breast cancer outcomes?

Green tea consumption and risk of hematologic neoplasms: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study)

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie